Our performance highlights
Integrated solutions that drive sustainable growth and expand patient access worldwide.
Our case studies demonstrate how our expertise, global network, and regulatory knowledge enable us to successfully supply medicines across diverse international markets. Each example reflects the challenges encountered in sourcing and distributing critical pharmaceuticals and how our team identified solutions to ensure timely, compliant supply.
Collaboration that improves treatment options for sickle cell patients in the UK
In exclusive partnership with Theravia, we are driving sustainable growth and improving nationwide access to Siklos® across the UK. Through targeted national key account management, deep NHS and haematology network expertise, and strong KOL advocacy, we are supporting specialist centres and strengthening treatment pathways for patients living with sickle cell disease. This case study explores how a focused commercial strategy, combined with disease insight and stakeholder engagement, is expanding access and delivering measurable impact in a complex healthcare environment.
.webp)
Commercialisation of Desferal® in Brazil, in partnership with Mitem Pharma
In partnership with Mitem Pharma, we are strengthening access to essential haematology treatments across Brazil. The successful transfer of Desferal® from Novartis, combined with a dedicated haematology sales force and a locally tailored commercial strategy, has reinforced our growing portfolio in the region.
Improving access to life-changing treatment for sickle cell patients in Saudi Arabia
As part of our long-term strategic partnership with Theravia, we have successfully expanded Siklos® into Saudi Arabia. This case study highlights how careful market preparation, KOL engagement, and national account management can accelerate access to essential treatments in a new territory.